About the Company
hercules technology growth capital, inc. (nyse: htgc) ("hercules") is the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including technology, biotechnology, life science, and energy & renewable technology industries, at all stages of development. since inception (december 2003), hercules has committed more than $4.6 billion to over 300 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing. at hercules, we provide venture debt to entrepreneurial companies at all stages of development to further their growth and help them achieve key milestones. in addition to the capital we provide, many times the access to our network of contacts and simple business advice can prove to be equally as valuable. we understand the importance of these intangibles because we, like the companies which choose hercules, also come from an entrepreneur
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $HTGC News
Hercules Capital Receives BBB- Affirmed Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.
Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of ...
bluebird (BLUE) Gets $175 Million Loan From Hercules, Shares Up
Inc. BLUE announced that it has received a $175 million five-year, term loan facility from Hercules Capital, Inc. HTGC. The ...
The Cash Cow Cavalry: 3 Stocks Leading the Charge to Profitability
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors care about the bottom line. What does this mean?
5 Virtually Unknown Stocks That Pay Huge Ultra-Yield Dividends
Passive income investors with a higher risk tolerance may want to check out five virtually unknown comanies that pay massive ...
Bluebird bio says it will refile 2022, 2023 financial statements
Bluebird’s shares fell Tuesday after the company said it would need to refile its consolidated financial statements for 2022 ...
Bluebird secures up to $175M in debt financing deal
Bluebird bio has gotten an initial loan of $75M, and is eligible for up to $50M more depending on the company hitting certain ...
Top 5 Ultra-High Yield Dividend Stocks To Buy in March
Investors love dividend stocks, especially the ultra-yield variety because they provide a significant income stream and give ...
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
Strategic investment in Beckley Psytech to accelerate the development of psychedelic-based therapies that fit within the two hour in-clinic ...
bluebird (BLUE) Misses on Q4 Revenues, Provides Portfolio Updates
(BLUE) revenues miss the Zacks Consensus Estimate in the fourth quarter. The company progresses with the launch of its three ...
Bluebird secures up to $175M financing amid gene therapy launches
Bluebird bio (NASDAQ:BLUE) said it has secured up to $175M in debt financing through an agreement with Hercules Capital (HTGC ...
Here Are My Top 10 Ultra-High-Yield Dividend Stocks to Buy in 2024
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
TriplePoint Venture Growth: 17% Yield Now A Red Flag
TriplePoint Venture Growth reported a larger-than-anticipated decline in net asset value and an increase in its payout ratio.
Loading the latest forecasts...